Sow Hang Teo - 12 Feb 2026 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Feb 2026, 11:00:39 UTC
Prior SEC filing
02 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Tattoli, Attorney-in-Fact

Key filing fact

Sow Hang Teo filed Form 4 for Core Laboratories Inc. /DE/ (CLB) on 17 Feb 2026.

Key facts

  • This page summarizes Sow Hang Teo's Form 4 filing for Core Laboratories Inc. /DE/ (CLB).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 17 Feb 2026, 11:00.

Change

  • Previous filing in this sequence was filed on 02 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002017091 Primary reporting owner

Teo Sow Hang

Relationship
CAO & Treasurer
Address
6316 WINDFERN ROAD, HOUSTON
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Signature date
17 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLB transaction Derivative

Performance Shares

Award

Transaction value
$0
Shares
+7,526
Change %
Price
$0.000000
Shares after
7,526
Date
12 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,526
Exercise price
$0.000000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Assuming the recipient's continued employment (or death or disability while employed) and the satisfaction of certain performances criteria set forth below, this award will vest on December 31, 2028, following the conclusion of a three-year performance period that began on January 1, 2026 and ends on December 31, 2028 (the "Performance Period"). At the end of the Perofrmance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return on Invested Capital ("ROIC") among the Bloomberg Peer Group ("BPG"), and 200% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile of ROIC (equivalent to 100% up to 200% of the award).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .